Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Immuncell-LC with temozolomide in newly diagnosed glioblastoma completed in Korea; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Immuncell-LC
• Temozolomide (Temozolomide)

Snippet

Sponsor: GC Cell Corporation | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2025-10-10